COPD Management

Selected news for the healthcare topic - COPD Management, collected since 10/2017. Recent stories appear in dovepress.com and news-medical.net. This healthcare topic shares news with GSK, GlaxoSmithKline and Respiratory Care.

Please provide a valid email address.
Shares Healthcare News With (link):
Other Healthcare Entities

Selected Headines

Date Headline (link) Source Relevant Snippet
11/30/2020 Factors Affecting Community Pharmacist's Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study dovepress.com ... public health. Many studies have confirmed that the professional services for COPD patients by community pharmacists can improve comprehensive benefits. However, there’s less research investigating the factors affecting community pharmacists’ knowledge about COPD management. Therefore, this study aimed to investigate the knowledge of COPD among community pharmacists in China and analyze the factors affecting community pharmacist’s knowledge about COPD management. Methods: This study employed a face-to ...
11/20/2020 National health groups offer support for COPD patients and caregivers amid pandemic news-medical.net ... and out of the hospital, especially for those living with COPD, which is already a high-risk disease for readmissions to the hospital.” Byron Thomashow, M.D, Chief Medical Officer, COPD Foundation Questions about COPD management in the COVID era?The Centers for Disease Control and Prevention (CDC) has identified those living with COPD among those at greater risk for the most severe complications from COVID-19. To protect their ...
11/19/2020 The caregiver difference: One man’s journey caring for his father’s COPD ask.com ... as part of the support system.A new survey from GSK conducted in collaboration with CHEST and COPD Foundations identified significant gaps in communication between patients and their doctors, which create barriers to optimal COPD management. The survey, which was fielded to 351 people with COPD, 151 caregivers, 249 primary care physicians and 252 pulmonologists, found that caregivers play a valuable role in bridging these gaps and positively impact care ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management PR Newswire ... manage high-risk patient populations and those who may be delaying their care. Clear Arch Health announced today the addition of new connected health devices to ensure timely clinical touchpoints for COVID-19 and COPD management. The new peripherals complement the company’s already rich ecosystem of connected health devices and will provide clinical teams access to patient generated health data to better manage high-risk patient populations and those who ...
9/17/2020 Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management tmcnet.com FREE eNEWSLETTERS TMCnet News Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management [September 17, 2020] Clear Arch Health Expands Device Ecosystem to Ensure Timely Clinical Touchpoints and Support for COVID-19 and COPD Management BOCA RATON, Fla. , Sept. 17, 2020 /PRNewswire/ -- Clear Arch Health , a leading provider of remote patient monitoring (RPM) and mobile personal emergency response system (mPERS ...
9/1/2020 Bilim Pharmaceuticals, H&T Presspart and Hovione Collaborate contractpharma.com ... a pharmaceutical specialist in the development of innovative pulmonary device technology, are collaborating to support Bilim Pharmaceutical’s launch into the Turkish market of Ventofor Combi Fix, a formulation of Budesonide Formoterol for Asthma and COPD management, delivered by the PowdAir Plus Dry Powder Inhaler (DPI). Treating Asthma in Turkey Worldwide over 500 million people suffer from Asthma and COPD. In Turkey, there is growing patient demand for effective, readily accessible ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease PR Newswire ... a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality ...
8/11/2020 Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease BioSpace ... a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world. GOLD's primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality ...
6/25/2020 Breztri Aerosphere Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial drugs.com ... support the strong clinical profile of Breztri Aerosphere in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of Breztri Aerosphere were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection ...
6/25/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial financialbuzz.com ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial BioSpace ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial gurufocus.com ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/24/2020 PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial Business Wire ... trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The ...
6/5/2020 Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring - ResearchAndMarkets.com Business Wire ... Growth Opportunities: Sound Analysis Technologies will Experience High Adoption for Remote Monitoring of Older Patients in Home Settings 3.2.5 Application Growth Opportunities: Non-contact Chronic Cough Sound Monitoring Can Play a Significant Role in COPD Management 3.3 Video Analysis Technology 3.3.1 AI-powered, Video-based Vital Signs Monitoring 3.3.2 3D Motion Tracking Technology for Estimating Heart Rate and Rhythm 3.3.3 Breathing Pattern Analysis Based on Acquired Video Data 3.3.4 Video ...
6/5/2020 Remote Patient Monitoring and COVID-19 - Mobile-based Platforms, AI-based Algorithms, and Video Analysis Defining New Approaches PR Newswire ... Growth Opportunities: Sound Analysis Technologies will Experience High Adoption for Remote Monitoring of Older Patients in Home Settings 3.2.5 Application Growth Opportunities: Non-contact Chronic Cough Sound Monitoring Can Play a Significant Role in COPD Management 3.3 Video Analysis Technology 3.3.1 AI-powered, Video-based Vital Signs Monitoring 3.3.2 3D Motion Tracking Technology for Estimating Heart Rate and Rhythm 3.3.3 Breathing Pattern Analysis Based on Acquired Video Data 3.3.4 Video ...
6/2/2020 Measuring disease activity in COPD: is clinically important deterioration the answer? biomedcentral.com ... medium-term outcomes compared with any single CID component alone, and that it can demonstrate differences in treatment efficacy in short-term trials. Given the widely acknowledged need for an individualized holistic approach to COPD management, monitoring short-term CID has the potential to facilitate early identification of suboptimal treatment responses and patients at risk of increased disease progression. CID monitoring may lead to better-informed clinical management decisions and ...
3/16/2020 COPD: Importance of Educating Patients on Proper Inhalation Technique clinicaladvisor.com Practitioners can play a vital role in providing education and training on correct inhalation techniques to enhance therapeutic benefit and optimal medication delivery. Treatment of COPD Maintenance pharmacotherapy with long-acting bronchodilators is the cornerstone of COPD management . Bronchodilators can be short-acting or long-acting . Long-acting bronchodilators include long-acting beta 2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs). When used together, the 2 medications have improved ...
11/26/2019 COPD Awareness Month – Take Control of Your Respiratory Heath supercarehealth.com ... Awareness Month? COPD Awareness Month is celebrated around the world throughout November and is designed as a way for individuals to learn more about this disease while providing increased support for those currently seeking COPD management. With over 15.3 million Americans currently diagnosed with COPD, most people know someone with this disease. However, it is highly likely that millions more adults have this disease but have not yet been diagnosed ...
11/26/2019 Diagnosed with COPD? you Can take charge Of Your Health! supercarehealth.com ... burden COPD can cause in your daily life. As a Clinical Pharmacist who focuses on improving patient outcomes, it is my passion to empower my patients with the knowledge and tools they need for COPD management and to overcome the fear and anxiety of being labeled with a Chronic Respiratory condition. Moment of Truth You just found out why you run out of breath so quickly, wheeze once in a ...
11/20/2019 World COPD Day: Pulmonologist Tells Everything You Ever Wanted To Know About COPD ndtv.com Drink plenty of fluids for COPD management Maintaining a healthy weight is also important Be on point with your medicines to control COPD World COPD Day: November 20 is observed as World Chronic Obstructive Pulmonary Disease (COPD) Day. This day is meant to raise awareness about COPD which is referred to a group of slowly progressing lung diseases. Emphysema and chronic bronchitis are common lung diseases. Emphysema slowly destroys air ...